• About
  • Licensing
  • Podcasting
  • Contact

AudioMedica.com

  • Public Health
  • Oncology
  • Cardiovascular
  • General Medicine

Drug-eluting Stents: Cost-Benefit Targeting?

  • — 12 Sep, 2005
AudioMedica News
AudioMedica News
Drug-eluting Stents: Cost-Benefit Targeting?
Drug-eluting Stents: Cost-Benefit Targeting?
00:00 /
RSS Feed
Share
Link
Embed
Matthias Pfisterer
Matthias Pfisterer

Drug-eluting stents and their additional benefit to low-risk patients were investigated in a cost-effectiveness analysis presented to the Stockholm cardiology meeting by Matthias Pfisterer from Basel. Audio Medica talked with him.
[audio:https://www.audiomedica.com/podcasting/14.Matt_Pfisterer-Drug-eluting_stents_may_confer_so_little_additional_benefit_to_low_risk_patients.mp3]

Click here for all the interviews from ESC 2005

You may also like...

  • Chronic Stable Angina: Should ESC Guidelines on Clopidogrel as Pre-Treatment to Planned Coronary Angiography be Changed? Chronic Stable Angina: Should ESC Guidelines on Clopidogrel as Pre-Treatment to Planned Coronary Angiography be Changed? 3 Sep, 2007
  • Evan Stein GAUSS STUDY: New alternative for LDL lowering in patients intolerant to statins 16 Nov, 2012
  • Drug Eluting Stent Shows Great Benefit in Chronic Total Occlusions Drug Eluting Stent Shows Great Benefit in Chronic Total Occlusions 3 Sep, 2007
  • COMMENTS COMMENTS 16 Nov, 2005
  • Previous story Fondaparinux: Better than Enoxaparin for Patients with Acute Coronary Syndromes?
  • Next story Enoxaparin Shows Safety in Angioplasty – STEEPLE Study
  • News

    • Mandeep Mehra MDCOVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
    • Ultrahypofractionated Radiation Just As Effective for Prostate CancerUltrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
    • Paracetamol Poisoning: 12-hour modified acetylcysteine treatment for paracetamol poisoning reduced side effects associated with standard regimen.Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
  • Related interviews

    • Ibrutinib: New Frontline Standard for Chronic Lymphocytic…
    • Genomic-led AML Clinical Decision Making Within Seven Days
    • Microbiome Diversity Key To Survival After Allogeneic…
    • Which Tasks Most Influence Pediatric PT Productivity,…
    • Volume CT Lung Cancer Screening Cuts Cancer Deaths 24 Per…
  • Home
  • Cardiovascular
  • Drug-eluting Stents: Cost-Benefit Targeting?

© Copyright 2022 AudioMedica.com. Typegrid Theme by WPBandit.